Veru (VERU) Competitors $3.25 -0.12 (-3.56%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$3.29 +0.04 (+1.35%) As of 08/29/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERU vs. MED, EL, IPAR, PBH, HLF, NUS, USNA, NATR, UTMD, and FTLFShould you be buying Veru stock or one of its competitors? The main competitors of Veru include Medifast (MED), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), Utah Medical Products (UTMD), and FitLife Brands (FTLF). Veru vs. Its Competitors Medifast Estee Lauder Companies Interparfums Prestige Consumer Healthcare Herbalife Nu Skin Enterprises USANA Health Sciences Nature's Sunshine Products Utah Medical Products FitLife Brands Veru (NASDAQ:VERU) and Medifast (NYSE:MED) are both small-cap personal products companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings. Do analysts rate VERU or MED? Veru currently has a consensus target price of $33.33, indicating a potential upside of 925.64%. Medifast has a consensus target price of $16.50, indicating a potential upside of 17.35%. Given Veru's stronger consensus rating and higher possible upside, analysts plainly believe Veru is more favorable than Medifast.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veru 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Medifast 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is VERU or MED more profitable? Medifast has a net margin of 0.76% compared to Veru's net margin of 0.00%. Medifast's return on equity of 2.00% beat Veru's return on equity.Company Net Margins Return on Equity Return on Assets VeruN/A -143.24% -85.22% Medifast 0.76%2.00%1.50% Do institutionals & insiders believe in VERU or MED? 47.2% of Veru shares are owned by institutional investors. Comparatively, 95.5% of Medifast shares are owned by institutional investors. 15.2% of Veru shares are owned by insiders. Comparatively, 2.9% of Medifast shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, VERU or MED? Veru has a beta of -0.72, indicating that its stock price is 172% less volatile than the S&P 500. Comparatively, Medifast has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Which has higher earnings and valuation, VERU or MED? Medifast has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeru$16.89M2.82-$37.80M-$2.20-1.48Medifast$480.45M0.32$2.09M$0.3243.94 Does the media refer more to VERU or MED? In the previous week, Medifast had 5 more articles in the media than Veru. MarketBeat recorded 6 mentions for Medifast and 1 mentions for Veru. Veru's average media sentiment score of 1.88 beat Medifast's score of -0.55 indicating that Veru is being referred to more favorably in the media. Company Overall Sentiment Veru Very Positive Medifast Negative SummaryMedifast beats Veru on 10 of the 16 factors compared between the two stocks. Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERU vs. The Competition Export to ExcelMetricVeruMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$47.64M$10.77B$5.67B$9.84BDividend YieldN/A1.85%3.93%4.04%P/E Ratio-1.4821.7983.1926.61Price / Sales2.8231.71451.26176.46Price / CashN/A24.7237.7059.65Price / Book3.103.4810.556.59Net Income-$37.80M$211.94M$3.27B$266.12M7 Day Performance-9.72%1.47%0.46%0.17%1 Month Performance-34.13%13.90%5.91%3.03%1 Year Performance-60.29%-7.79%48.81%19.98% Veru Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERUVeru2.5519 of 5 stars$3.25-3.6%$33.33+925.6%-60.1%$47.64M$16.89M-1.48230MEDMedifast3.6258 of 5 stars$14.07-1.5%$16.50+17.3%-24.3%$154.64M$602.46M43.97870Analyst RevisionELEstee Lauder Companies4.1924 of 5 stars$88.72-2.8%$87.80-1.0%+1.3%$31.92B$14.79B-28.2557,000Insider TradeIPARInterparfums4.3225 of 5 stars$115.00-1.0%$162.00+40.9%-8.8%$3.69B$1.45B23.05530News CoveragePositive NewsPBHPrestige Consumer Healthcare4.749 of 5 stars$65.69-1.5%$93.33+42.1%-7.9%$3.23B$1.14B15.42540Analyst RevisionHLFHerbalife4.1553 of 5 stars$9.47-2.8%$11.50+21.5%+15.4%$976.04M$4.99B2.998,600Positive NewsNUSNu Skin Enterprises4.0562 of 5 stars$12.02-0.9%$6.88-42.8%+30.9%$594.99M$1.73B5.983,100News CoverageInsider TradeUSNAUSANA Health Sciences4.2531 of 5 stars$31.87-1.2%$36.00+13.0%-21.4%$582.17M$854.50M17.701,700News CoveragePositive NewsNATRNature's Sunshine Products3.0703 of 5 stars$16.59+1.2%$19.67+18.5%+24.4%$292.58M$460.82M22.42850Positive NewsHigh Trading VolumeUTMDUtah Medical Products2.6995 of 5 stars$60.34-1.0%N/A-8.4%$195.37M$38.83M16.13180News CoveragePositive NewsFTLFFitLife Brands3.5012 of 5 stars$18.20+7.1%$22.00+20.9%+11.6%$170.90M$64.47M21.6720Positive News Related Companies and Tools Related Companies MED Alternatives EL Alternatives IPAR Alternatives PBH Alternatives HLF Alternatives NUS Alternatives USNA Alternatives NATR Alternatives UTMD Alternatives FTLF Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERU) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERU Stock Alerts